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Though there have been many advances in providing access to linked and integrated biomedical data
across repositories, developing methods which allow users to specify ambiguous and exploratory queries
over disparate sources remains a challenge to extracting well-curated or diversely-supported biological
information. In the following work, we discuss the concepts of data coverage and evidence in the context
of integrated sources. We address diverse information retrieval via a simple framework for representing
coverage and evidence that operates in parallel with an arbitrary schema, and a language upon which
queries on the schema and framework may be executed. We show that this approach is capable of
answering questions that require ranged levels of evidence or triangulation, and demonstrate that appro-
priately-formed queries can signiﬁcantly improve the level of precision when retrieving well-supported
biomedical data.
Published by Elsevier Inc.1. Introduction
Analytical methods that rely on the integration of information
from multiple sources are becoming increasingly common in bio-
medical research. For instance, determining the likelihood of a pro-
tein as a drug target or assessing the therapeutic value of a
compound requires careful examination of experimental and de-
rived data; information accumulated as a result of this may be
cross-referenced across biomedical repositories whose contents
collectively span the molecular, chemical, phenotypic and clinical
spectrums [1,2].
Though biomedical data is abundant and publicly-available in
an ever-growing number of databases (over 1000 in molecular
biology alone [3]), it is costly and effort-intensive to identify the
most relevant information for any one task. Even starting from a
single data source such as EntrezGene, one may easily ﬁnd cross-
references to other sources, potentially leading to an exponential
number of possible choices. Retrieval of relevant data of high con-
ﬁdence in such a situation can take considerable time for a single
gene – time that is compounded for high-throughput biomedical
research.
In the following work, we present a simple, proof-of-concept
framework and method for representing federation-based data
provenance and evidence using a hierarchical ontology centered
around membership. This hierarchy may be maintained separate
from any common data model, and when given an ordering and
mappings to query results represented in an external schema,Inc.can be used as a evidence cutoff function for information retrieval.
To demonstrate utility of the added level of abstraction, we further
present a query language as a means of obtaining data from multi-
ple, interlinked repositories. This query language expressively
accommodates retrieval of well-triangulated data based on source,
data type and provenance, the speciﬁcs of which may be deﬁned by
the user using restrictions on the content of the data retrieved or
means of retrieval.2. Background
2.1. Linking over biomedical repositories
The interconnected nature of many biological data sources
allows one to imagine the space of biomedical data as a directed
graph where each vertex within the graph represents any individ-
ual record in any database, and the edges reference other records
within or outside of that database (see Fig. 1). Taking a mediated
approach, we can further deﬁne a schema S  hC;I;Mi over this
data; C is the set of generalized entities within the schema with
n : n correspondences to sources I viaM mappings.
Use of a graph-based representation allows queries to be ex-
pressed in terms of satisfying and valid paths. When C supports
inheritance, as in frames, queries can even be posed with a limited
level of abstraction; if inter-source links, deﬁned in M, are anno-
tated with additional descriptive information then the queries on
S would effectively be done over a semantic network, the expres-
sive beneﬁts of which are numerous [4,5]. Furthermore, adapting a
common schema across any number of sources and materializing
links between them not only allows one to query myriad sources
EntrezGene UniProt
dbSNP PANTHER 
InterPro
TIGRFAM 
Fig. 1. References between six different biological databases. Arrows represent
links from an individual record in each database to records in another.
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sible paths from one source or schema entity to another, via other
sources or schema entities [6].
2.2. Path selection
However, all databases are not created equal and levels of scien-
tiﬁc validation vary across and within sources (e.g., the contrast be-
tween TrEMBL and Swiss-Prot, the latter being manually curated).
Thus, certain paths may be preferable to others, and selection of
paths may be difﬁcult based on the size and number of records
and links; a method of ﬁltering for or highlighting choice results,
given some retrieval task, is necessary to navigate abundant data.
Because these data record relationships may be represented as
paths, one method is to employ regular expressions as a means
of specifying restrictions going from one data type to another.
Even with the expressivity afforded by the use of regularly-
described paths, some queries are by nature challenging to answer
without additional information or overhead. Continuing within the
context of genomic research, it is difﬁcult and unwieldy to answer
queries such as: ‘‘give me the proteins in my organism of study
involved in biosynthesis whose functions were elucidated using
at least manually-curated computational methods”, or ‘‘within a
particular loci, return all functional SNPs associated with a gene
whose involvement in a pathway is supported via multiple types of
experiments and analyses”. Queries such as these express levels of
uncertainty commonly encountered in active biomedical research,
and implies that any information retrieved satisﬁes minimal cover-
age and evidence, in addition to the other requirements.
2.3. Query methods over disparate biomedical data
Given the disparate nature of many biomedical resources, there
have been several query systems and methods speciﬁcally devel-
oped or adapted to deal with retrieving data from heterogeneous
or remote scientiﬁc sources. XQuery, an XML query language, has
been adapted for purposes of interrogating a variety of structured
data such as XML ﬁles, ontologies and relational databases in a col-
laborative setting for the Human Brain Project [7]. Later work ex-
tended XQuery usability for non-experts by the development of a
graphical interface for interactive query formation [8]. QIS (Query
Integrator System) relies on a combination of SQL-like syntax
and XML to allow a user to formulate a query [9]. The core of the
system is a set of modules that mediate requests between a client
and service in a scalable fashion. Notable features of QIS include
automatic schema change determination (including a robust warn-
ing structure that notiﬁes a user during querying if a source’s sche-
ma may have changed) and a Web-based user interface.
More closely related to our work are query methods that rely on
the paths and links formed between external references of dat-abases. Such approaches can quickly generate large amounts of
data of varying relevance, and provide a browsing paradigm that
can be appropriate for exploratory research [10]. PQL, based on
the StruQL [11] query language for Web content management,
relies on path constraints placed on inter- and intra-databases
references [12]. Similarly, BioNavigation builds upon this path-
constraining approach by further ranking paths based on path cost
and cardinality [22]. Notably, while these methods are capable of
retrieving data from disparate data sources, they cannot explicitly
query over minimal coverage and evidence.2.4. Data quality and query methods over disparate biomedical data
Related to the challenge of querying biomedical data is ascer-
taining from where it came, how it has been processed and how
much trust or belief to assign it. Capturing, recording and annotat-
ing biologic information with metadata regarding its origin, nature
of alterations and quality has become an area of interest for many
disciplines of science [13–15]; such tasks can include prospective
examination of data generated for validation or comparison, and
tracing the processes which transformed data to generate a repli-
cable workﬂow [16,17]. Methods of tracking provenance, or lineage,
have been developed to address these and similar needs.
Systems which support one or more of these capabilities have
the potential to help manage the varied data that is often collected
from multiple repositories and experiments. Under the model
implemented within the Karma provenance system, provenance
information is recorded for data as it moves through a workﬂow
[18]. Within this system, queries may be posed by a blend of both
API calls and direct SQL queries to a back-end MySQL database.
Similarly, the Taverna workbench supports the capture of prove-
nance metadata during the execution of workﬂows for the myGrid
project using RDF [19]. Other Semantic Web technologies have
been examined as a means of representing provenance information
for biomedical data management [15]. A strength of these systems
is a traceable audit trail upon which queries regarding evidence
may be posed to discern lineage, and the use of standardized rep-
resentations encourage inter-system integration and data dissem-
ination. At the same time, some of these technologies lack abilities
desirable in a system where queries permit some level of ambigu-
ity, e.g., SPARQL does not natively support regular path expres-
sions, and queries using relational database-driven systems can
become unwieldy as sources are added or the provenance model
increases in complexity.
While related to workﬂow data capture, the problem we are
most interested in for this work is to improve the ability of
biomedical researchers to navigate data across heterogeneous
resources, particularly for exploratory phases. The methods de-
scribed below execute path-based queries with user-determined
levels of ambiguity over distributed resources remotely, without
the requirement of a database back-end to store or drive queries.
Relying on a top-down approach that does not require a compre-
hensive systemwith end-to-end tracking, the implementation pro-
vides robust querying abilities in the context of evidence and
coverage with comparatively little cost or overhead.3. Methods
3.1. Modeling data diversity and evidence
To practically illustrate coverage and evidence as it pertains to
our work and integrated data sources, refer to Fig. 2 of a general-
ized query q against a set of databases A; B and C. Let A represent
a semi-manually curated database of known structures and their
functions, B a database of experimentally-derived data and C a
A B C
q
x y z
Fig. 2. Simple example graph showing how information that is supported through a
greater diversity of sources or types may not be easily-discernable amongst a
multitude of other data.
Fig. 3. Portion of the declarations of membership and rank order for a domain
hierarchy oriented around exploratory sequence annotation. The ﬁrst two entities
(preﬁxed by the :dom command) create two domains, one based on short sequence
alignments, and the other on pathway-related information; within each of these
domains, various sources and classes native to the data integration engine’s schema
claim membership. The last entity (preﬁxed by :ord) deﬁnes the order for the
domain, in increasing rank, as appropriate for the task at hand.
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records directly linked from A; B and C (among them x; y; z).
Examining cardinality alone, a possible conclusion is that x is a
more preferable result to y as there is one more path from q! x
than q! y, and this indeed may be true in the case of an investi-
gator interested in ﬁnding targets whose structures are elucidated.
On the other hand, y may be preferable as a well-triangulated re-
sult, as it is being linked via two different sources of information.
Queries that are sensitive to coverage would allow a user to specify
requirements on how diversely-supported their results are with
respect to evidence without having to necessarily enumerate spe-
ciﬁc data sources or types.
From another perspective, an investigator interested primarily
in speciﬁc genera of organisms and their protein structure may
trust data from sources A; C more than B. Queries capable of exe-
cution over evidentiary knowledge would allow a user to express
their preferred data origin needs, again without having to explicitly
state the exact sources themselves.
3.2. Modeling a domain knowledge hierarchy
Being able to succinctly query on minimal requirements of evi-
dence or coverage abstractly requires further metadata than nor-
mally provided in a traditional mediated schema such as the one
deﬁned formally inS (Section 2). Formally, we introduce a domain
hierarchy H  hD;Ni, where each element (domain) d 2 D is an
evidence type, such as information that was ‘‘derived from assay”
or data ‘‘elucidated from crystallization”; H contains relations to
any individual source or entity s 2S via correspondences n : d#s
in N. In this way, any element of C or I from S may then be
claimed as a member of an element of D. Multiple inheritance on
D would further allow us to state, for example, that structural
information from TargetDB may be ‘‘elucidated from crystalliza-
tion”, which is a type of ‘‘structural experiment” and, transitively,
‘‘experiment” and ‘‘manually-determined” (see Fig. 3).
Mapping the domains of the hierarchy to actual sources or enti-
ties allows one to differentiate between the origin of various re-
sults, and pose questions that include restrictions on evidence
coverage. Additional utility is added by imposition of an ordering
upon the domains, entities and sources such that any given ele-
ment may have precedence over another. This allows for various
sources, records or links to have preference over others for any gi-
ven task, as with the previous example of data sources A; B; C.
The content of the domain hierarchy can yield useful metadata
regarding the results, and can be used to answer queries that may
be ambiguous with respect to data coverage and evidence. Notably,
we deﬁne these concepts as an external component to any schema,
and rely on loose couplings from the domains to the schema. As a
consequence, the order among the domains may be changed with-
out having to disturb or alter any pre-existing class descriptionswithin a schema, maintaining scalability in how both the schema
and the domain hierarchy are composed. This added layer of
abstraction further allows for ﬂexibility of ranking as requirements
change, since the exact same data model may be used for any num-
ber of distinct tasks but return appropriately different results
depending on the domain order imposed.
3.3. Supporting domain-aware queries
A primary objective of this research is to incorporate support for
the concepts of data coverage and evidence within a query-capable
framework. Recall that there have beenmany systems in the past to
support structured queries;while someof these approaches, such as
PQL and BioNavigation allow for somewhat ambiguous path queries
(e.g., wildcard proxies for record elements), none of these ap-
proaches directly address the complementary issues of coverage
and evidence. Subsequently, we developed a query language built
to allow a user to easily write queries which directly consider infor-
mation diversity and provenance, DaRQL (pronounced dar-kle and
short for Domain-aware Regular Query Language).
Based loosely on SQL syntax for familiarity and usability pur-
poses, and with similar regular expression capabilities as PQL
and BioNavigation to traverse paths, DaRQL further supports
user-deﬁned restrictions on evidence and coverage for results.
DaRQL queries have the following format:
TARGET hbindings for selected nodesi
FROM hbindings for start nodesi
RESTRICT hpath and node constraintsi
where TARGET speciﬁes any number of nodes a user wishes to bind
to a variable for later reference, FROM speciﬁes nodes that serve as
Fig. 4. Example showing a basic query in DaRQL.
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straints to place upon the nodes and paths, represented via regular
expressions.
As an example, consider the query in Fig. 4. The variables ?t and
?g on line 1 are bound to all nodes in the graph that are either
Terms or Genes, respectively (including any hyponyms, as deﬁned
by the schema and domain hierarchy); all paths, by default, origi-
nate at ?q, deﬁned as any Query node within the graph. Variables
may also be bound to speciﬁc data sources (enclosed by ’’), as
well as evidence types deﬁned in the domain hierarchy (preﬁxed
with @), e.g., ?x~’EntrezGene’, ?x~@StructureBased.
The statements following the RESTRICT clause are the path and
node restrictions that any path found in the graph must meet, and
predicates contained in {} (e.g., line 4) represent a speciﬁc regular
expression over a path. The path expression in Fig. 4 would only be
satisﬁed with a path that begins at a Query that transitively reaches
a Gene, which has a direct link to a Term. Path expressions support
most regular expression characters.1 For example, (*) is a transitive
closure on a relation between speciﬁed terms, connected via the join
(.) symbol; disjunction and conjunction among nodes are expressed
using the (?x|?y) and (?x&?y) constructs.
Non-path restrictions in Fig. 4 must also be met. The ﬁrst spec-
iﬁes that the Gene identiﬁed in the path must be of human origin
(where ?x:Y refers to any attribute Y of some record in the graph,
?x). The second references the order of the Term ?t using a re-
served function order, and enforces a constraint on any result that
a valid ?t must be supported by more than sequence-based motif
evidence, as determined by the ordering in the domain hierarchy.
Another reserved function, divcount, returns the number of dis-
tinct (as determined recursively via domain subsumption) types
of evidence that lead to a result. Using path and node constraints,
as well as functions for accessing a node’s evidence and coverage
characteristics, allows a user to formulate queries in DaRQL with
a signiﬁcant amount of ambiguity while taking into account data
noise reduction.3.4. Implementation of model
For feasibility testing of querying using coverage and evidence
parameters, we developed and coupled a DaRQL interpreter with
an integration engine to allow us to query over live results. Data
integration across sources was handled using an open-source gen-
eral-purpose data integration system2, as was our lexing and pars-
ing module.3 Brieﬂy, PyDI is a general-purpose data integration
system that permits a user to pose a seeding query, such as an acces-
sion number, in the form of an entity-attribute-value tuple whose
vocabulary is deﬁned within the schema [20]. To illustrate, a user
interested in seeding a query based on the human acyl-CoA protein
related to long chain fatty acid mutation may submit the query via
the following tuple: (Gene, #ID, ‘‘51”), where ‘‘51” is the gene identi-1 ?x.+.?y is unsupported, as it can be equivalently stated in schema form as
?x.Entity.?y.
2 PyDI, http://pydi.sourceforge.net.
3 PLY, http://www.dabeaz.com/ply.ﬁer of interest; conversely, a user, faced with an unknown protein,
may choose to submit a sequence instead, with the appropriate
parameters. In the case of the ﬁrst query, the initial resultwill be a sin-
gle node corresponding to the EntrezGene entry for the protein; in the
latter case, the resultwouldbe anynumberof recordswith alignments
to the sequence query that meet user-deﬁned requirements.
When these parameters are submitted to the integration en-
gine, any sources which support the speciﬁed entity and attribute,
as speciﬁed by the schema, will be queried. Any data reachable
from the seed across myriad repositories is then returned indis-
criminately; such results may then be used to retrieve even further
data. This paradigm of integrating data through browsing and
daisy-chaining has been used in the past for exploring biologic data
in disparate sources, and provide retrieved data to the user in the
form of a query graph of interconnected results [21–23]. We imple-
mented the DaRQL interpreter over PyDI, and deﬁned loose cou-
plings from the domain hierarchy to the system schema (refer to
Fig. 5 for system components).
A query is processed as follows: a user initiates an exploratory
(non-DaRQL) query via the data integration system (refer to
Fig. 5, step 1). Results from this initial, exploratory query are gath-
ered via the integration engine by reformulating the query into the
native format of the individual data sources (step 2). When sources
respond with query results, the data is translated into the entity-
attribute-value format of the integration engine (step 3). The
exploratory query can recursively re-query current results, thus
expanding any query graph to a size limited only by the source-
to-source mappings deﬁned in the schema. To ﬁlter the results,
the user may then submit a DaRQL query to the graph (step 4),
which passes it on to the interpreter for processing. Bindings are
resolved to entities, sources and domains and the validity of the
terms in the query are checked against both the domain hierarchy
and the data integration system’s schema (step 5).
Prior to execution, a pathing plan is created to minimize tra-
versal cost; paths that would not yield any valid answer, given
the constraints on sources, classes and domains, would not be fol-
lowed. At this point, the query engine inspects the terms expressed
within the path and variable constraints. Any evidence and cover-
age requirements (per order and div keywords) within the query
are cross-referenced with the domain hierarchy to ensure that any
results satisfy the minimum levels of evidence or coverage re-
quested, or fall within the deﬁned range. For example, a terminal
node of a path constraint which also requires a minimum coverageFig. 5. Above image is the schematic architecture of the querying and integration
system; note that the query module and its subparts (lexer/parser, query planner)
are modularized from the rest of the system.
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age can only be traced two or fewer domains.
Once a plan is ready, a series of deterministic ﬁnite state ma-
chines (DFSMs) are created to check the constraints over the live
query graph, each representative of an expression in the RESTRICT
clause. The DFSMs are evaluated individually using a non-greedy
search, each navigating a singular path in the graph to determine
the path’s validity (step 6). If a path does not meet all of the deﬁned
restrictions, the end of the path is noted as invalid with respect to
the query. Alternatively, any terminal node within the graph which
contains all successful DFSMs is a valid result that meets all the
restrictions deﬁned in the RESTRICT clause. The results may then
be serialized into XML form as a subgraph of the full query graph
that contains only the nodes and edges that satisfy the query (step
7; see Fig. 6).4. Results
4.1. System performance
Depending on the restrictiveness of the query formulated, use
of the query planner increased execution speed on average 35%,
a difference we found to be statistically signiﬁcant (see Fig. 7).
One limitation of relying on a DFSM, however, is that query evalu-Fig. 6. Sample truncated output from graph serialization; the above query
identiﬁes paths to GO terms that run through genes, pathway-based data and
have more than three different ‘‘types” of other data leading to them (i.e., two other
domains in addition to pathway-based).ations over graphs that have a higher ratio of edges to nodes (i.e.,
are more well-connected) or queries whose paths are generally
unrestrictive (e.g., {?q.*.?t}, where ?t is not directly linked from
?q and no further constraints are expressed) are more time-
expensive to execute. Conversely, even somewhat large graphs
with relatively few well-connected nodes may be evaluated
quickly.
4.2. Model utility
Ultimately, the goal of our knowledge representation and que-
rying model is to improve a researcher’s ability to interrogate dis-
parate data sources efﬁciently by facilitating queries that easily
accommodate ambiguity in ranges and whose speciﬁc formulation
is independent of data sources. To this end, we tested our imple-
mentation of DaRQL over a set of queries aimed at retrieving
‘‘high-quality” GO terms – that is, GO terms whose annotation is
supported by experimental evidence. For this experiment, the ac-
tual evidence codes provided by the GO annotations revealed dur-
ing the querying and retrieval process were not used as part of the
evaluation. In doing so, we attempted to measure the utility of our
approach in retrieving the most well-supported annotations a
priori based on memberships to domains and entities, and levels
of coverage only.
We randomly selected 500 proteins from the H. sapiens prote-
ome from UniProt 4 which possessed one or more GO annotations
supported by evidence at the experimental level, i.e., ‘EXP’, ‘IDA’,
‘IPI’, ‘IMP’, ‘IGI’ and ‘IEP’.5 These 500 proteins, and their experimental
GO terms, serve as the test set against ﬁve DaRQL queries targeted at
retrieving gene annotations at varying levels and ranges of strin-
gency (see Table 1, queries A–E).
Annotations retrieved by the ﬁve queries were scored using two
ﬂavors of precision and recall: macro-average and micro-average.
Macro-average precision was calculated by computing the preci-
sion for each protein individually, then averaging over all 500 que-
ries. Let n be the number of proteins in the total test set, Px the set
of experimental terms for protein x and Qx the set of terms in a
query graph for protein x. The macro-average precision for one of
the ﬁve test queries is then calculated by:
PrMacro ¼ 1n
Xn
i
jexperimental terms in Qi for Pij
jall terms in Qij
; ð1Þ
and macro-average recall with:
ReMacro ¼ 1n
Xn
i
jexperimental terms in Qij
jall experimental terms for Pij : ð2Þ
Micro-average precision was computed using:
PrMicro ¼
Pn
i jexperimental terms in Qi for PijPn
i jall terms in Qij
; ð3Þ
and micro-average recall, likewise:
ReMicro ¼
Pn
i jexperimental terms in Qi for PijPn
i jall experimental terms for Pij
: ð4Þ
Using these four metrics, we were able to measure the overall pre-
cision and recall at the protein-level (macro-average) as well as at
the annotation term level (micro-average) for the test queries. For
this test, only exact GO annotation matches were considered as cor-
rect; terms not listed in the gold standard, though they themselves
may be parents to a correct annotation, were marked as incorrect.4 See http://www.uniprot.org.
5 A complete list of GO evidence codes is available at http://www.geneontolo-
gy.org/GO.evidence.shtml.
0Fig. 7. Query execution times for 99 randomly selected proteins from yeast, without query planning and with query planning for a query with many restrictions, and for a
loosely-deﬁned query; solid horizontal lines mark the means for each query, and dotted horizontal lines the standard deviations. Benchmarks were done on an Intel dual core
2.66 GHz Linux machine with 3 GB of RAM.
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of the ﬁve test queries based on all 500 test proteins. The metrics
were also computed for the full query graph for each of the test
proteins, absent any DaRQL queries, thus allowing for comparison
of our methodology against a baseline. Furthermore, we used two
additional annotation sets generated from the full query graph,
where 20% and 80% of the annotations for each protein were ran-
domly selected as results. These two ﬁnal sets, rand20 and rand80,
were used as a control to ensure that by ﬁltering the query graph
via DaRQL we were not merely measuring any effects normally
present when a subset of the query graph is returned.Table 1
Queries tested against the DaRQL implementation and their associated translation
against full query graphs (cf. Fig. 8).
Name Query
A 1: TARGET ?~g’AmiGO’
2: FROM ?s~ProteinSequenceQuery
3: RESTRICT
4: {?s.*.@NonRepository.*.?g},
5: divcount(?g)>2,
6: order(?g)>=@CurationBased
B 1: TARGET ?~g’AmiGO’
2: FROM ?s~ProteinSequenceQuery
3: RESTRICT
4: {?s.*.Gene.*.?g},
5: divcount(?g)>3
C 1: TARGET ?~g’AmiGO’
2: FROM ?s~ProteinSequenceQuery
3: RESTRICT
4: {?s.*.Gene.*.?g},
5: divcount(?g)>2
D 1: TARGET ?~g’AmiGO’
2: FROM ?s~ProteinSequenceQuery
3: RESTRICT
4: {?s.*.’InterPro’.*.?g},
5 : order(?g)>=@PathwayBased
E 1: TARGET ?~g’AmiGO’
2: FROM ?s~ProteinSequenceQuery
3: RESTRICT
4: order(?g)>=@ExperimentBasedThe experiment was conducted thusly: the initial step involved
generation of the baseline full query graphs from the data integra-
tion system (as described in Section 3.4); the sequences of each of
the 500 test proteins were queried against a subset of the data
sources currently supported by PyDI: EntrezProtein, BioCyc (pro-
teins), KEGG (proteins), TIGRFAM, InterPro (motifs) and PDB (struc-
tures). From these initial sequence queries, further queries were
recursively generated to return other components of these reposi-
tories (e.g., KEGG pathways) and other, external data sources (e.g.,
EntrezGene, AmiGO); recursive query calls were continued until
the size of the graph did not increase, resulting in 500 full querys. GO terms retrieved from these queries were used in a pairwise comparison
Description
Retrieves GO terms linked from motif-, conserved domain-
or protein family-based databases that are supported
by more than two domain types and whose levels of
evidence is equal to or greater than semi-manual curation
Retrieves GO terms whose path to the query passes through
at least one Gene entity, as deﬁned in the schema, and which
are also supported by more than three different domain types
Retrieves GO terms whose path to the query passes through
at least one Gene entity, and which are also supported
by more than two different domain types
Retrieves GO terms linked from a speciﬁc data source (InterPro),
and which is supported by a level of evidence equal to or greater
than that of pathway support
Retrieves GO terms supported by a level of evidence equal
to or greater than that of experimental results
Table 3
Example of annotations found for the protein PNMT_HUMAN (P11086). Results are
for the baseline and the ﬁve test queries; all terms shown were retrieved by the
baseline method, and terms retrieved by any of the ﬁve test queries are denoted by an
‘’ in the appropriate column. The experimentally-supported annotations, per the
gold standard, are shown in bold. Notably, the GO terms most prevalent across all
queries (GO:0016740, ‘transferase activity’; GO:0008168, ‘methyltransferase activity’)
are parent terms to the gold standard term GO:0004603 (‘phenylethanolamine
N-methyltransferase activity’).
Baseline A B C D E
GO:0003674  
GO:0004603   
GO:0005625  
GO:0005737   
GO:0005829   
GO:0008112   
GO:0008168     
GO:0008757 
GO:0010243 
GO:0016740    
GO:0030748   
GO:0031100 
GO:0042418 
GO:0042423   
GO:0042493 
GO:0046498 
GO:0046500 
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the graphs to determine which terms within each query graph sat-
isﬁed the query criteria; for rand20 and rand80, 20% and 80% of the
graphs’ terms, respectively, were randomly selected. Finally,
macro- and micro-average precision and recall metrics were col-
lected for each test query and compared to the measures found
for the baseline graphs and the random sets. Notably, UniProt is
absent as a source, as we derived the gold standard experimental
GO terms from this data source.
The ﬁndings of the query utility evaluation are shown in
Table 2. As expected, the full graph – returning all terms without
posing any queries – exhibited high recall and low precision; indis-
criminate retrieval of GO annotation terms across data repositories
successfully identiﬁed 98% of all experimental terms. However,
only 5.9% of all retrieved terms were experimentally supported.
Performances for both random sets were similar, with no apprecia-
ble increases in precision as recall fell.
While the recall values for the ﬁve test queries were generally
lower than those of the full graph, precision values were higher
in cases than those of the full graph and random results. In one
case, query C, precision increased at the macro-level 46.7% over
the full graph, with a recall decrease of only 4.4%. Three of the ﬁve
test queries showed signiﬁcantly better performance over the full
graph and random controls, as determined by non-parametric
tests. Nonetheless, utility for each individual query varied, and
two queries displayed very poor results across both precision and
recall. One of these queries declared a speciﬁc source as a path
requirement while simultaneously constraining returned annota-
tions to pathway-supported information (query D); the other per-
mitted return of only terms whose data types or resources were
known to involve experimental ﬁndings (query E) (see Table 3).
Pairwise examination of individual protein annotation term
scores further illustrates that precisions are generally higher for
three of the test queries (A–C), and conversely lower for the
remaining two (D, E; cf. Fig. 8). In all cases, it is clear that the
majority of instances where the query underperformed in compar-
ison to the full graph occur where all experimental terms are omit-
ted from the results, i.e., where points lie along the axis of ‘No
query’. For the poorly-scoring queries, D and E, the vast majority
of results exhibit this behavior, suggesting that for the purposes
of retrieving experimental annotation terms these queries were
likely too stringent.
As the evaluation metrics of the various queries differed, so too
did the features of the query graphs themselves. The plots in Fig. 9
brieﬂy illustrate some of the characteristics of the protein test set
as well as the resulting query graphs. Notably, the vast majority
of the test set is comprised of proteins associated with six or less
experimental terms; indeed, proteins with ﬁve or less terms con-
tribute 50% of all terms.Table 2
Performance results of GO term data retrieved after queries A–E were executed
(shown in Table 1) on the test set of human proteins; ‘Full graph’ corresponds to using
all terms as available in the full graph, absent any querying. Findings are shown at the
macro- and micro-level for both Pr and Re. Macro-average signiﬁcance was measured
using paired non-parametric rank sum tests, with correction; instances where the
query results are not signiﬁcantly different from the full graph ðp > 0:01Þ or either of
the random sets are denoted by the appropriate subscripts.
Query PrMacro PrMicro ReMacro ReMicro
Full graph 0.082 0.059 0.988 0.980
rand20 0.075 0.057 0.165 0.180
rand80 0.082 0.059 0.781 0.773
Query A 0.146 0.145 0:820r80 0.823
Query B 0.171 0.161 0.898 0.928
Query C 0.154 0.146 0.944 0.955
Query D 0:050r20 0.065 0.080 0.065
Query E 0:055r20 0.049 0.618 0.695Furthermore, we were interested in how the performance met-
rics were reﬂected within the log-normal distribution of the fre-
quency of terms within the query graphs. The plots of Fig. 10
show frequency curves for the query graphs, stratiﬁed by median:
the lower half (red dotted) are the frequencies of the F1 score for
graphs whose number of results fell below the median; the upper
half (blue solid) are the frequencies for graphs whose number of
results are larger than the median. Because of the nonlinearity of
the distributions, we found no strong correlation between the size
of the results returned and the F1 score. It is clear from a visual
inspection, and conﬁrmed with statistical testing, that larger query
graphs (i.e., graphs with more returned results) tended to produce
better metrics. The shifts in distribution ranges are most stark for
the best-performing test queries, A–C, whereas for the full graph
and the lower-performing queries, the upper and lower halves
trended toward the same ranges. These ﬁndings suggest that the
optimal use of our presented query model for researchers may be
in highlighting well-supported data when faced with a large num-
ber of results; this utility may diminish with the number of records
retrieved.5. Discussion
5.1. Design motivations
We have described a method of representing data coverage and
evidence in the context of integrated, heterogeneous data sources.
The result is a proof-of-concept artifact,6 feasible methodology, and
performance and utility evaluations of a model for incorporating the
concepts of range and minimality into queries for biomedical data
integration. While our framework was kept intentionally simple
and logically-based, we believe that it is ﬂexible enough to accom-
modate more complex and nuanced additions as necessary. For
example, in many ﬁelds of research probabilistic representation is
a de facto standard for expressing uncertainty in evidence and prov-
enance; the domain hierarchy can accommodate ﬁner-grained anno-
tations of relationships or orderings that reﬂect a user’s belief in
individual sources, similar to approaches taken by others [24,25].6 See supplementary information (Appendix A) for software and step-by-step
instructions on use.
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ambiguous and ranged queries over integrated biomedical data,
we have opted for a loose coupling between a hierarchy that man-
ages how the data is internally represented (the schema) and a
hierarchy that manages the evidence and diversity of data (do-
mains). The primary motivating factor behind this design decision
was to keep each individual component of the data integration and
querying system simple and easily manageable. A beneﬁcial side
effect of this goal is that systems which rely on a basic data model
would not require dramatic or extensive changes to support do-
main-aware queries; deﬁning the domain hierarchy, its ordering
and mappings to the entities in the schema could be done without
disturbing the schema.
As a demonstration of this querying model, we opted for a top-
down data integration approach that did not require any data
source to offer Web services, a route taken by previous federated
models of querying [12]. Furthermore, though our implementation
permitted standardized output of results in the form of XML, our
choice to limit the use of markup encoding was driven by a desire
to minimize the overhead and footprint of the system implementa-
tion, and improve speed by relying primarily on internal data
structures for representation. From the authors’ experience, this
was a fair tradeoff for an implementation whose primary purposewas not necessarily to form the backbone of a production system,
but rather to explore a new method of querying disparate biomed-
ical data using levels of ambiguity.5.2. Limitations and future work
Wewere encouraged that the results of the evaluation validated
the general approach, which found that overall DaRQL queries with
consideration of evidence and coverage were able to succinctly im-
prove system precision. At the same time, we note that perfor-
mance naturally depended on the query crafted, a task often left
to an individual researcher. Though this is a difﬁculty generally
faced when pruning data, one possible solution with respect to
the model we have outlined would be to provide more granularity
when discriminating between data records. Our domain imple-
mentation focused primarily on sources (e.g., PDB) and classes
(e.g., ‘Pathways’), but can be extended to include attributes or
descriptors at a ﬁner-grained level (e.g., expect values for align-
ments), thereby giving the user more control over the speciﬁcity
of the query.
Indeed, an important limitation our ﬁndings illustrate is that
manual researcher interaction remains an important ﬁlter when
dealing with biological data. While the queries improved precision
over the baseline approach, scores still remained relatively low;
the best precisions reported were between 0.14 and 0.17, and
not nearly high enough to endorse automated application of que-
ries for the purposes of identifying well-supported annotations.
Identifying methods of improving the evaluation metrics is a key
future challenge, though the analysis we have done here provides
clues as to where to direct effort. For example, scores tended to be
lower for query graphs that returned fewer results (see Fig. 10),
and as yet our methodology does not take advantage of knowledge
concerning the state of the query graph overall. A smaller number
of results imply a less well-known protein for which some terms
within a query would be too restrictive, and where requiring
too many different domains or speciﬁc data sources may be
detrimental.
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above methods are not replacements to manual review, but instead
should serve as aids to user-driven scientiﬁc research. In this
regard, providing a way of prioritizing attention can be valuable,
particularly when such methods permit scientists to pose ambigu-
ous or speciﬁc queries over multiple biological sources as needed.
To this end, in the future we plan to extend the system to support
other data repositories, domains and attributes, thus expanding
generalizability across tasks and resources. While this work dem-
onstrates the technical practicality of implementing our proposed
model, we have not yet done a study involving potential users in
regards to the practicality of use and usability, which is one future
direction of this research.
Also, though our preliminary work was implemented via a no-
vel query language for feasibility, ﬂexibility and relative simplicity
in syntax, we envision the concepts of data diversity and coverage
incorporated in future standardized languages such as SPARQL,
either formally or as well-supported extensions; we expect that
these technologies shall continue to mature, and their weaknesses
addressed (such as regular path support [26]). Indeed, formal rep-
resentations of data uncertainty is already under consideration by
the World Wide Web Consortium [27], and desiderata and models
in the form of the Open Provenance Model have gained traction
from annual challenges and community discussion [28,29]. Meth-
ods formally adopted for representing uncertainty and trust could
be extended to handle task domains and data diversity such that
navigation and integration becomes less onerous for users.
Independent of any method or approach taken, however, it is
important that a user is able to formulate their questions and nav-
igate their search results in a way that is optimized for their pref-
erence and task. This is an issue that is all the more important as
the boundaries between medicine and biological research blur
and repositories become more cross-disciplinary in usage and
application. In this regard, methods of query formulation, such as
that provided through DaRQL that give a searching user control
over the level of ambiguity, speciﬁcity and trustability of their re-
sults can be a valuable aid.Acknowledgments
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